Figure 3

Cytokine and chemokine analysis of patients in the PS and SM groups during the severe stage of COVID-19, (A) Schematic diagram illustrating patients in the PS and SM groups. (B) Differences in the expression of TNF-α between the PS and SM groups during the initial severe phase of COVID-19. The p value was calculated using unpaired two-sided Student’s t tests. *P < 0.05. (C–I) Quantitative analysis of lymphocytes, monocytes, white blood cells, platelets, CRP, ALT, and AST in patients in the PS and SM groups during the severe stage of COVID-19. The p value was calculated using unpaired two-sided Student’s t tests. P > 0.05 indicates no significant difference, and these instances are not marked in the figure.